C26-Ceramide as highly sensitive biomarker for the diagnosis of Farber Disease-Reference-Cited by-同舟云学术

C26-Ceramide as highly sensitive biomarker for the diagnosis of Farber Disease

Published:2017-07-21 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Cozma Claudia,Iurașcu Marius-Ionuț,Eichler Sabrina,Hovakimyan Marina,Brandau Oliver,Zielke Susanne,Böttcher Tobias,Giese Anne-Katrin,Lukas Jan,Rolfs Arndt

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-06604-2.pdf

Reference55 articles.

1. Sands, M. S. Farber disease: understanding a fatal childhood disorder and dissecting ceramide biology. EMBO Mol. Med. 5, 799–801 (2013).

2. Sugita, M., Dulaney, J. T. & Moser, H. W. Ceramidase deficiency in Farber’s disease (lipogranulomatosis). Science 178, 1100–1102 (1972).

3. Park, J.-H. & Schuchman, E. H. Acid ceramidase and human disease. Biochim. Biophys. Acta 1758, 2133–2138 (2006).

4. Li, C. M. et al. The human acid ceramidase gene (ASAH): structure, chromosomal location, mutation analysis, and expression. Genomics 62, 223–331 (1999).

5. Ehlert, K. et al. Farber disease: clinical presentation, pathogenesis and a new approach to treatment. Pediatr. Rheumatol. Online J. 5, 15 (2007).

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a Multiplexed Sphingolipids Method for Diagnosis of Inborn Errors of Ceramide Metabolism;Clinical Chemistry;2024-08-29

2. Adiponectin overexpression improves metabolic abnormalities caused by acid ceramidase deficiency but does not prolong lifespan in a mouse model of Farber Disease;Molecular Genetics and Metabolism Reports;2024-06

3. Hepatomegaly and Splenomegaly: An Approach to the Diagnosis of Lysosomal Storage Diseases;Journal of Clinical Medicine;2024-03-02

4. Glycosphingolipids and central nervous system–related diseases;Glycosphingolipids in the Central Nervous System;2024

5. Neuronal progenitor cells-based metabolomics study reveals dysregulated lipid metabolism and identifies putative biomarkers for CLN6 disease;Scientific Reports;2023-10-29